Hans Wenzel

8PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2025
Adjuvant Chemoradiotherapy or Radiotherapy Alone for Early Squamous Cervical Cancer with a Single Surgical-Pathological High-Risk Factor.

Ester P Olthof, Hans H B Wenzel, Jacobus van der Velden

|Apr 01, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren

|Jul 17, 2024
Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early-stage high-intermediate or high-risk endometrial cancer.

Ruben C G Koek, Hans Wenzel, Geertruida N Jonges

|Feb 03, 2023
Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands: A nationwide study.

Koen De Decker, Hans H B Wenzel, Joost Bart

|Jul 09, 2022
Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study.

Mieke L G Ten Eikelder, Floor Hinten, Anke Smits

|Apr 28, 2022
Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.

Ester Paulien Olthof, Hans Wenzel, Jacobus van der Velden

Pageof 2

Frequent Collaborators

4 joint publications

Ester Paulien Olthof

3 joint publications

Ruud L M Bekkers

3 joint publications

Jacobus van der Velden

2 joint publications

Roy F P M Kruitwagen